Supplier Type
- Manufacturer
- Reagent
- Trader
Supplier Region
- Hyderabad(11)
- Mumbai(3)
- New Delhi(1)
- Maharashtra(2)
- Pune(2)
- Gujarat(3)
- Karnataka(1)
- Ahmedabad(1)
- Beijing(1)
- Nagpur(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT95%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.86%
- 99.85%
- 99.73%
- 99.42%
- 99.29%
- 99%
- 98.60%
- 98.12%
- >98%
- 98%
- 97-99%
- 97-99 %
- 97.57%
- 97%
- 97 %
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95.48%
- 95%
- >95%
- >92%
- 90%
- >90%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 25MG
- 1g
- 5g
- 25g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 1MT
- 95NLT %
-
(2-Chloro-5-((3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4-ethoxyphenyl)methanone
2169998-23-4
-
Dapagliflozin Impurity 3
-
Dapagliflozin Impurity 55
3093141-55-7
-
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1R)-
1373321-04-0
-
Dapagliflozin Impurity 10
960404-86-8
-
Dapagliflozin Open Ring
2100872-88-4
-
Isosulfan blue Keto N-Oxide Impurity
-
(3R,4R,5R,6S)-2-(acetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
461432-24-6
-
EZM-K
191330-56-0
99% Lamivudine EP Impurity C 69-72-7
Keto Analogue, Calcium-2-Oxo-3-Phenylpropionate (A-Ketoanalogue Of Phenylalanine, Calcium-Salt)
(R)-3-Boc-aminopiperidine Alogliptin Impurity 309956-78-3
Dapagliflozin propanediol monohydrate 960404-48-2
Diphenyl Acetonitrile, C14H11N, Cas Number: 86-29-3 86-29-3










